Endocrinology News and Research

Latest Endocrinology News and Research

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.

26 Oct 2004

Call for a Senate Inquiry into the pharmacy industry in Australia

With the current Pharmacy Agreement expiring on 30 June 2005 and the current Senate configuration in place until the same date, Dr Glasson said the timing is perfect for a comprehensive review of the protected environment in which the pharmacies operate.

26 Oct 2004

Researchers found that sedentary lifestyles can lead to higher medical costs

Lack of physical activity is costly not just to people’s health but to their wallets as well, a new study suggests.

25 Oct 2004

Arizona will receive 22,500 additional doses of flu vaccine

Arizona Governor Janet Napolitano announced today that Arizona will receive 22,500 additional doses of flu vaccine as early as Wednesday, and will distribute the vaccine to local health departments in the next week.

25 Oct 2004

Obese patients have higher health care costs

Compared to nonobese persons, obese patients had higher average health care costs over a one-year period, according to an article in the October 25 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

25 Oct 2004

Studies examine risk factors and potential consequences associated with prehypertension

A substantial proportion of Americans have prehypertension (blood pressure above optimal levels, but not clinical hypertension) which is associated with an increased prevalence of other risk factors for heart disease and stroke and is also associated with potential increased risk for hospitalization and death

25 Oct 2004

Fatbuster drug targets obesity

A new drug to combat obesity at a cellular level is in the sights of a University of Queensland scientist.

25 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

A single change in a person’s DNA can contribute to a range of life-shortening risk factors

A woman with hypertension, low magnesium levels, and a cooperative family allowed scientists to pinpoint the mutation, which affects the genes of the mitochondria — the energy-producing power plants of the cell that are passed from mother to offspring.

25 Oct 2004

To avoid metabolic syndrome is relatively simple – 30 minutes of physical activity once a week

Metabolic syndrome is a condition that is affecting thousands of Canadians and is putting them at risk of heart disease and stroke, especially those aged 50 and over.

25 Oct 2004

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Rosiglitazone, a drug taken to help improve blood sugar levels, also helps boost the effectiveness of a treatment for opening clogged arteries, according to a study in the November issue of Diabetes Care.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

Australian Medical Association slams pharmacy guild

Australian Medical Association President, Dr Bill Glasson, today branded moves by the Pharmacy Guild of Australia to have pharmacists usurp some of the core public health functions of community GPs as mischievous, irresponsible and a poor prescription for Australian patients.

25 Oct 2004

Newly discovered gene could be a significant contributor to diabetes in Americans

A gene involved in the action of insulin is associated with type 2 diabetes and the body’s response to insulin, report scientists at Wake Forest University Baptist Medical Center.

25 Oct 2004

The aging American population means that more people are at risk for stroke

A leading stroke researcher says the aging of the American population means that more people are at risk for stroke, and unless new approaches are developed to reduce stroke incidence, it will surpass heart attacks and cancer as the major cause of long-term disability and premature death.

22 Oct 2004

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

The discovery that the Lag-3 gene acts as a brake to prevent immune system responses from running out of control solves a mystery that has puzzled researchers since the gene was discovered 14 years ago.

22 Oct 2004

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Over 18 months, researchers at University Hospitals of Cleveland and Case Western Reserve University studied the frequency and prevalence of musculoskeletal (MSK) complaints in obese patients before and after undergoing gastric bypass surgery.

21 Oct 2004

Research opens new possibilities for the treatment of metabolic disorders such as diabetes and obesity

For the first time, researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected with the Catholic University of Leuven have shown clearly that receptors in yeast cells detect and react to nutrients in the cell.

21 Oct 2004

Gene variations explain why people with type 2 diabetes are at much greater risk for coronary artery disease

New studies by an international team of scientists led by Joslin Diabetes Center have found variations in a gene that help explain why people with type 2 diabetes are at much greater risk for coronary artery disease, the leading cause of death for this group.

21 Oct 2004

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Researchers from the Johns Hopkins Children's Center say a group of drugs known as "atypical antipsychotics" that are commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance, a condition that increases the risk of developing Type 2 diabetes and heart disease later in life.

21 Oct 2004

Endocrinology News and Research

Latest Endocrinology News and Research

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Call for a Senate Inquiry into the pharmacy industry in Australia

Researchers found that sedentary lifestyles can lead to higher medical costs

Arizona will receive 22,500 additional doses of flu vaccine

Obese patients have higher health care costs

Studies examine risk factors and potential consequences associated with prehypertension

Fatbuster drug targets obesity

Infectious diseases physicians call for financial incentives for industry

A single change in a person’s DNA can contribute to a range of life-shortening risk factors

To avoid metabolic syndrome is relatively simple – 30 minutes of physical activity once a week

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Who should and who should not get a flu shot?

Australian Medical Association slams pharmacy guild

Newly discovered gene could be a significant contributor to diabetes in Americans

The aging American population means that more people are at risk for stroke

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Research opens new possibilities for the treatment of metabolic disorders such as diabetes and obesity

Gene variations explain why people with type 2 diabetes are at much greater risk for coronary artery disease

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Endocrinology News and Research

Latest Endocrinology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in